InvestorsHub Logo

DewDiligence

07/01/16 10:06 AM

#202316 RE: DewDiligence #202169

OCRX set an all-time low yesterday, perhaps caused by someone’s not wanting it listed in their EoQ portfolio. (Today’s bounce is consistent with such a motive.)

DewDiligence

08/03/16 4:10 PM

#203093 RE: DewDiligence #202169

OCRX has enrolled 195 of 230 patients in STOP-HE and expects to complete enrollment in 4Q16:

http://finance.yahoo.com/news/ocera-therapeutics-reports-second-quarter-200500105.html

The 195 number is up from 180 six weeks ago (#msg-123459268) implying an enrollment rate of about 2.5 patients per week. If the enrollment rate stays at this level, it will take until mid-November to hit 230, meeting the 4Q16 guidance above.